Trial Site Detail

 

Drug:
AZD6244 plus Temsirolimus
Trial:
MEK Inhibitor AZD6244 With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery
Conditions: Sarcoma
Trial Status:
Ongoing, but not recruiting

 

University of Pittsburgh Cancer Institute

     
Pittsburgh , PA 15232
USA

 

Principal Investigator:
Contact:
 Clinical Trials Office - UPMC Cancer Centers 412-647-8073
Activation Status of this Site:
 Closed
Notes about this Site:
University of Pittsburgh Cancer Institute Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.